|
2024
|
P/S
|
Patient support, including providing information via a website to patients regarding insurance ma... |
|
|
P/S
|
Providing information on chronic kidney disease, and promoting the importance of testing for chro... |
|
|
P/S
|
Promoting public awareness of diabetes and heart disease |
|
2023
|
P/S
|
Promoting public awareness of lung diseases and conditions and their symptoms, prevention and tre... |
|
2022
|
P/S
|
promoting awareness of diabetes, heart disease and heart failure, and their symptoms, treatment a... |
|
|
P/S
|
promoting awareness of interstitial lung diseases, their symptoms, prevention and treatments prov... |
|
|
P/S
|
promoting awareness of generalized pustular psoriasis and its symptoms, treatment and prevention ... |
|
2021
|
P/S
|
promotional services by manufacturers of heart and diabetes pharmaceutical products, namely, prom... |
|
|
P/S
|
Providing on-line non-downloadable publications in the nature of reports in the field of managed ... |
|
|
P/S
|
Providing information in relation to the cost management of health care Providing information on ... |
|
2019
|
P/S
|
Promoting awareness of various diseases and conditions, their symptoms, detection, prevention and... |
|
|
P/S
|
Maintaining registries of patients with interstitial lung diseases; promoting awareness of inters... |
|
|
P/S
|
Maintaining registries of patients with idiopathic pulmonary fibrosis; promoting awareness of idi... |
|
|
P/S
|
Promoting awareness of atrial fibrillation, its prevention, symptoms and treatment Healthcare ser... |
|
|
Invention
|
Antibodies targeting a complex comprising non-classical hla-i and neoantigen and their methods of... |
|
|
P/S
|
Promoting public awareness of diabetes and heart disease and their symptoms, prevention and treat... |
|
|
P/S
|
Maintaining registries of patients with idiopathic pulmonary fibrosis and with interstitial lung ... |
|
2018
|
P/S
|
Promoting awareness of Type 2 diabetes and the diabetic heart, their symptoms, treatment and care... |
|
|
P/S
|
Providing medical information to persons with Type 2 diabetes on the diabetic heart, its symptoms... |
|
|
P/S
|
Providing information to idiopathic pulmonary fibrosis patients regarding insurance matters and p... |
|
|
P/S
|
Maintaining a registry of patients with interstitial lung diseases; promoting awareness of inters... |
|
|
Invention
|
Anti-trkb antibodies. The present invention relates to novel agonistic anti-TrkB antibodies and t... |
|
|
P/S
|
Promoting awareness of diabetes and heart disease, their symptoms and treatment Providing informa... |
|
|
P/S
|
Promoting awareness of scleroderma, its symptoms, detection, prevention and treatment Providing i... |
|
2015
|
P/S
|
Promoting public awareness of idiopathic pulmonary fibrosis, its symptoms, its prevention and its... |
|
|
P/S
|
promoting awareness of atrial fibrillation, stroke risks and their causes and treatment, and the ... |
|
2013
|
P/S
|
Promoting public awareness of idiopathic pulmonary fibrosis, its symptoms and treatment Providing... |
|
|
P/S
|
Providing information via a website to patients regarding insurance matters and payment options |
|
2012
|
Invention
|
T cell proteins and nucleotides encoding the same.
The present invention relates to mouse and hu... |
|
2011
|
Invention
|
Ikkalpha and ikkbeta specific inhibitors.
A method for modulating NF-κB dependent gene transcrip... |
|
|
Invention
|
Clinical management system and method.
An automated data processing method for obtaining clinica... |
|
|
Invention
|
Methods and compounds for the diagnosis of inflammatory disease and identification of pharmacolog... |
|
2010
|
P/S
|
[ Printed media, namely, brochures and pamphlets about chronic obstructive pulmonary disease ] Pr... |
|
|
Invention
|
Methods for modulating ikkα activity. A method for modulating NF-κB dependent gene transcription ... |
|
|
Invention
|
Pyrimidine derivatives. The present invention relates to trisubstituted pyrimidines of formula (I... |
|
|
P/S
|
Antivirals; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical ... |
|
2009
|
Invention
|
Antibodies for guanylyl cyclase receptors. Monoclonal antibodies that act as potentiators, stimul... |
|
|
Invention
|
T cell proteins and nucleotides encoding the same. The present invention relates to mouse and hum... |
|
|
Invention
|
Dabigatran for percutaneous interventional cardiac catheterisation.
The invention relates to a n... |
|
|
Invention
|
1,6 naphthridines useful as inhibitors of syk kinase. Disclosed are compounds of formula (I):
8 ... |
|
|
Invention
|
Methods for improving cell line activity in immunoisolation devices.
Methods for maintaining and... |
|
2008
|
Invention
|
Method of treating diseases and conditions associated with an altered level of amyloid beta pepti... |
|
|
Invention
|
Synthesis of 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonic acid amides.
Disclosed is a multi... |
|
|
Invention
|
Cytokine inhibitors. Disclosed are compounds of formula (I)
which inhibit production of cytokin... |
|
|
Invention
|
Clinical management system and methods.
An automated data processing method for obtaining clinic... |
|
|
Invention
|
1,6 naphthyridines useful as inhibitors of syk kinase. Disclosed are compounds of formula (I):
8... |
|
2007
|
Invention
|
H-imidazo[1,2-α]imidazole-3-sulfonylamino]-propionamide. Derivatives of [6,7-dihydro-5H-imidazo[1... |
|
|
Invention
|
Method for administering birb 796 bs.
Disclosed are methods of administering BIRB 796 BS, a p38 ... |
|
|
Invention
|
Method for generating secondary phosphines. 3 is an alkyl species comprising a β-hydrogen, not in... |
|
|
Invention
|
Anti-cytokine heterocyclic compounds. Disclosed compounds of formula (I)
which inhibit producti... |
|
2006
|
Invention
|
Intercellular adhesion molecules and their binding ligands.
The present invention relates to int... |
|
|
Invention
|
Process for making heteroaryl amine intermediate compounds. Disclosed are processes to produce a ... |
|
|
Invention
|
Stereoselective synthesis of certain trifluoromethyl-substituted alcohols. A process for stereose... |
|
|
Invention
|
Cytokine inhibitors. Disclosed are compounds of formula (I)
6 are defined herein. The compou... |
|
|
Invention
|
Method for improving the ability of patients suffering from lung diseases to participate in and b... |
|
|
Invention
|
Substituted 3-amino-thieno[2,3-b] pyridine-2-carboxylic acid amide compounds and processes for pr... |
|
|
Invention
|
Fluorescent probes for use in protein kinase inhibitor binding assay. d of the probe for the kina... |
|
|
Invention
|
Cytokine inhibitors. Disclosed are compounds of formula (I)
y are defined herein. The compounds ... |
|
|
Invention
|
Glucocortioid mimetics, methods of making them, pharmaceutical compositions, and uses thereof. Co... |
|
|
Invention
|
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof. Compou... |
|
|
Invention
|
Substituted [1,4]diazepino[1,2-a]indoles and azepino[1,2-a]indoles as anti-cytokine inhibitors. T... |
|
|
Invention
|
Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell ... |
|
2005
|
Invention
|
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof. C... |
|
|
Invention
|
Use of alpha-adrenergic blockers for the treatment of dysmenorrhea. Use of an alpha-adrenergic bl... |
|
|
Invention
|
Use of alpha-adrenergic blockers for the treatment of dysmenorrhea.
A method of treating primary... |
|
|
Invention
|
Fluorescence polarization assay for determining histidine decarboxylase activity. A fluorescence ... |
|
|
Invention
|
Method and system for assisted culling and reformatting of encoded microtubes. A method and syste... |
|
|
Invention
|
T cell protein and nucleotides encoding the same.
The present invention relates to mouse and hum... |
|
2004
|
Invention
|
Crystal structure of the itk kinase domain.
Disclosed are polypeptides encoding the ITK kinase d... |
|
1994
|
P/S
|
pharmaceutical preparations for human use in the treatment of duodenal ulcer, gastric ulcer patho... |
|
|
P/S
|
pharmaceutical preparations for human use containing as an active ingredient, a histamine H2-rece... |
|
1993
|
P/S
|
anti-viral preparations for human use |
|
1990
|
P/S
|
pharmaceuticals, specifically for treatment of chronic-obstructive pulmonary diseases, comprising... |
